Preclinical applications and studies

  1. Streamline And Accelerate A Drug Development Plan Using The 505(b)(2) Pathway 2/19/2013

    An international pharmaceutical company approached Camargo Pharmaceutical Services to help navigate the Food and Drug Administration (FDA) 505(b)(2) approval pathway for a promising drug under development designated for patients with cardiovascular disease. Product X is a prodrug that is converted in one metabolism-dependent step to produce the active metabolite of an approved drug.

  2. Accelerating Preclinical Studies With Project Tracking And Optimization Software 2/13/2013

    A large pharmaceutical company with globally distributed preclinical R&D operations including externalized services implemented an advanced assay/ study tracking and optimization system in conjunction with its enterprise electronic lab notebook.